Min-Ho Choi Selected Research

Min-Ho Choi Research Topics

Disease

14	Clonorchiasis 12/2012 - 06/2002
7	Infections 08/2017 - 09/2003
6	Neoplasms (Cancer) 07/2021 - 04/2009
5	Cholangiocarcinoma 01/2019 - 04/2009
3	Reinfection 08/2017 - 03/2004
2	Cysts 08/2018 - 03/2012
2	Toxocariasis 05/2015 - 08/2013
1	Colonic Neoplasms (Colon Cancer) 07/2021
1	Hypoxia (Hypoxemia) 07/2021
1	Eosinophilia 08/2020
1	Schistosomiasis (Bilharziasis) 02/2020
1	Cystitis 02/2020
1	Filarial Elephantiasis (Lymphatic Filariasis) 01/2020
1	Helminthiasis (Helminthiases) 01/2020
1	Disease Progression 08/2019
1	Spinal Stenosis (Stenosis, Spinal) 02/2019
1	Ganglion Cysts (Ganglion) 08/2018
1	Ocular Toxoplasmosis 08/2018
1	Giardiasis 01/2018
1	Metaplasia 02/2017
1	Rhinitis 06/2015
1	Sparganosis 02/2014
1	Communicable Diseases (Infectious Diseases) 12/2012
1	Inflammation (Inflammations) 01/2012
1	Asthma (Bronchial Asthma) 01/2012
1	Respiratory Hypersensitivity 01/2012
1	Fibrosis (Cirrhosis) 06/2009
1	Carcinogenesis 09/2008
1	Amebiasis (Amoebiasis) 07/2007
1	Dizziness (Lightheadedness) 03/2007
1	Anaphylaxis (Anaphylactic Shock) 03/2007
1	Urticaria (Hives) 03/2007
1	Pruritus (Itching) 03/2007
1	Dyspnea (Shortness of Breath) 03/2007
1	Trematode Infections (Fasciolopsiasis) 10/2003
1	Enterobiasis 09/2003
1	Neoplasms, Cystic, Mucinous, and Serous 09/2002

Drug/Important Bio-Agent (IBA)

7	Praziquantel (Biltricide)FDA Link 02/2020 - 10/2003
6	CarcinogensIBA 01/2019 - 09/2008
6	AntigensIBA 05/2015 - 06/2002
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 02/2005
4	CytokinesIBA 08/2017 - 06/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2021 - 06/2020
2	Albendazole (Albenza)FDA Link 08/2020 - 08/2019
2	Dimethylnitrosamine (Nitrosodimethylamine)IBA 06/2016 - 01/2015
2	AllergensIBA 06/2015 - 01/2012
2	Immunoglobulin G (IgG)IBA 05/2015 - 02/2014
2	Interleukin-4 (Interleukin 4)IBA 03/2012 - 01/2012
2	Ether (Diethyl Ether)IBA 08/2011 - 09/2003
2	Formaldehyde (Formol)FDA Link 08/2011 - 09/2003
2	TabletsIBA 12/2006 - 10/2003
1	Actins (F Actin)IBA 07/2021
1	caprolactoneIBA 07/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2021
1	Transcription Factors (Transcription Factor)IBA 07/2021
1	Thomsen-Friedenreich antibodiesIBA 08/2020
1	Sorafenib (BAY 43-9006)FDA Link 06/2020
1	AntibodiesIBA 06/2020
1	Keratin-19 (Keratin 19)IBA 01/2019
1	Retinaldehyde (Retinal)IBA 08/2018
1	Ethanol (Ethyl Alcohol)IBA 01/2018
1	antineoplaston A10 (A 10)IBA 01/2018
1	Immunoglobulin E (IgE)IBA 08/2017
1	NitrosaminesIBA 02/2017
1	dicyclanilIBA 06/2016
1	Cysteine Proteases (Cysteine Protease)IBA 02/2014
1	ChemokinesIBA 03/2012
1	Concanavalin AIBA 03/2012
1	OvalbuminIBA 01/2012
1	Interleukin-5 (Interleukin 5)IBA 01/2012
1	Methacholine Chloride (Methacholine)FDA Link 01/2012
1	Interleukin-12 (IL 12)IBA 01/2012
1	Interleukin-13IBA 01/2012
1	Complex MixturesIBA 01/2012
1	DNA (Deoxyribonucleic Acid)IBA 08/2011
1	Cytochrome P-450 CYP3AIBA 03/2011
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2009
1	LactonesIBA 04/2009
1	parthenolideIBA 04/2009
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2009
1	SesquiterpenesIBA 04/2009
1	Peptide Hydrolases (Proteases)FDA Link 07/2007
1	Indicators and Reagents (Reagents)IBA 12/2005
1	Methylprednisolone FDA LinkGeneric 03/2004
1	AnthelminticsIBA 09/2003

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 03/2011 - 04/2009
1	Mass Drug Administration 01/2020
1	Laminectomy 02/2019
1	Oral Administration 08/2018
1	Therapeutics 03/2011
1	Aftercare (After-Treatment) 03/2009
1	Hysterectomy 09/2002